In our previous work, a number of new nitrogen-containing bisphosphonates (N-BPs
I
t is known that several nitrogen-containing bisphosphonates (N-BPs) as the class of phosphorus compounds have important biomedical properties [1, 2] . Alendronate, ibandronate, risedronate created on their basis are effective drugs for such human skeletal system treatment as the Pedzhet's disease, primary hyperparathyreosis, myeloma, osteogenesis violations and malignant diseases of a bone tissue associated with the hypercalcemia [3, 4] . Moreover, N-BPs have been established as promising candidate drugs for the treatment of pathogenic parasitic infections caused by Plasmodium spp., Leishmania major, trypanosoma cruzi and other via the parasitic farnesyl pyrophosphate synthase (FPPS) inhibition [5, 6] . N-BPs as the energy source are on parasitic acidocalciosomes for the calcium metabolism and for the supporting of the cell pH level [7] .
On the other hand, FPPS of fungi, including C.albicans, takes part in the biosynthesis of ergosterol which is the main component of their cellular membrane [8] .
In our previous work [9] , it was assumed the functional similarity FPPS of microscopic fungi and parasitic protozoan as the organisms belonging to one Eucariota kingdom. In our work, the developed predictive QSAR models for the inhibition activities of N-BPs against FPPS from L. major using a data set of 97 compounds were presented. N-BPs with predictive activities were synthesized and estimated against C. albicans. The received experimental results of anti-Candida activity of the studied N-BPs confirmed the prediction results.
In the present study, we demonstrate the created homology FPPS C. albicans model and the docking analysis of active anti-Candida N-BPs into its active center as the confirmation of the earlier stated hypo thesis.
Materials and Methods
All studied N-BPs (Scheme 1) [9] were screened for their in vitro activity against fungi C. albicans M 885 ATCC 10231 and its clinical fluconazole resistant isolate strains using the agar diffusion technique [10] . Compound 7 was synthesized and tested as a known FPPS L. major inhibitor [11] . Fluconazole (FL), as a known antifungal drug, was tested as a positive control. Two drugs, alendronate (AL) and risedronate (RS), were used as N-BPs with known FPPS inhibition activity [12] and antiparasitic proper ties [13] . The 0.5 McFarland standard has been used as a reference to adjust the fungus suspensions turbidity and 1•10 9 CFU/ml (colony forming units in 1 ml) has been applied as a final cell inoculum. [16] with applying BLOSUM-62 matrix and Gap costs (11, 1) .
А preliminary search for evolutionarily related sequences was performed using the SWISS-MODEL Template Library (SWISS-MODEL server) [17] . The searching was conducted by BLAST [18] and HHBlits [19] for analysis of protein structures similar to FPPS C. albicans sequence. Homology models were created based on the results ranking of the templates. ERRAT [20] and PROCHECK [21] were used to quality validation of FPPS C. albicans homology model.
Created homology model FPPS C. albicans was used for the protein-ligand docking studies conducted similarly to our earlier works [22, 23] using AutoDock Tools (ADT) (ver.1.5.6) [24] . The structure of FPPS A-subunit was selected and stored as a PDB file by Accelrys DS (ver. 2.5.5) [25] . Two Mg 2+ ions and four water molecules which are part of the active center were added to the model (similarity to FPPS 4K10 (PDB: 4K10) [26] . Also, all protein hydrogens were added using ADT and no Bond Order method and the macromolecule atoms were renumbered. The calculated (by Gasteiger method) partial charges were added and the prepared protein structure was saved in PDBQT format.
The structures and conformations of studied ligands were obtained using ChemAxon Marvin Sketch 5.3.735 [27] and were saved in Mol2 format. The optimization of the ligands and energy minimization were performed by software Avogadro v1.1.1 [28] . "Auto Optimization Tool" was used by applying the MMFF94s force field and the steepest descent algorithm. Torsions angles and partial charges of ligands were changed by ADT and the ligand structures were saved in PDBQT format.
The prepared protein structure and optimized ligands were used for the docking analysis by AutoDock Vina 1.1.2 [29] . The box center (x = 39.593, y = 67.686, z = 85.156) was set into the ligand center of FPPS A-subunit 4K10. The grid of 30×30×30 points with grid spacing of 1.0 Å was used. The software package Accelrys DS was used for the visuali-
Scheme 1. Synthesis of N-BPs 1-7
zation and the analysis of the protein-ligand interactions.
results and discussions
Results of testing of N-BPs are presented in the Table. The data presented in Table show that compounds 1 and 3 exhibit highest activity against sensitive C. albicans M 885 ATCC 10231 strain and its resistant clinical isolate. Zones of inhibition formed by these compounds under conditions of high microbial loading as 1•10 9 colony forming units (CFU) in 1 ml significantly exceeded those formed using FL (a known antifungal drug) both against sensitive fungi strain and against drug-resistant clinical isolate of C. albicans. Both studied strains were sensitive to drugs alendronate and risedronate which are known FPPS inhibitors applied at the treatment of human skele tal system and pathogenic parasitic infections and against compound 7 as known inhibitors of FPPS L. major.
The received experimental research results indicate a molecular action mechanism of N-BPs associated with FPPS C. albicans.
Further researches were conducted using docking analysis of active N-BPs 1, 3 and known FPPS inhibitors 7, alendronate and risedronate in the active site of FPPS C. albicans homology model.
Protein sequences FPPSs C. albicans and L. major were investigated and compared using Protein BLAST (NCBI) and such operating parameters
activity (inhibition zone diameters, mm) of studied N-BPs against fungi C. albicans strains
Note: contents of all compounds on a disk was 0.1 µМ, NA -no activity
Compounds
The microbial loading, CFU in ml 1•10 (Fig. 1) .
The obtained results (Fig. 1) indicate the significant similarity of the enzymes primary structure. So, the sequence identity was 34%, the sequence similarity was 53% and a number to gaps was 5%.The secondary structure similarity, the binding sites and the active sites of FPPSs were studied by Accelrys DS (Fig. 2) . Fig. 2 has demonstrated a significant similarity also a secondary structure of enzymes. The similari ty is noted in the area of Mg 2+ binding sites, active sites and substrate binding sites. The creation of a homology model was begun with a preliminary search of sequences related to the FPPS using the SWISS-MODEL template library and 50 templates were generated. The template 4K10.1.А was used for developing of the homology model of FPPS C. albicans (Fig. 3) .
Created model is optimal considering the values of resolution (2.3 Å), QMEAN (-2.16), GMQE (0.73), GSQE (0.83) indicators. The quality estimation of the built FPPS C. albicans model was conducted by ERRAT and PROCHECK. ERRAT-web server results showed high model quality. The overall quali ty factor for the subunit A was 94.260 and for the subunit B was 96.049 (Fig. 4) .
PROCHECK-web server analysis has also been confirmed the good quality of 3D model FPPS by using Ramachandran plot analysis (Fig. 5) .
Fig. 1. Protein BLaSt results of FPPS C. albicans and FPPS L. major by application of Needleman-Wunsch Global Align Protein Sequences

Fig. 2. a comparison of secondary structure, binding sites and active sites of FPPS C. albicans and FPPS L. major by Accelrys DS, red -α-helixes, blue -β-sheets and gray -disordered regions
Ramachandran plot results indicated that 91.5% of the protein residues were distributed in the favored regions, 6.9% -in the additionally allowed regions, 1.1% -in the generously allowed regions and 0.5% -in the disallowed region. Thus, the created 3D structure of FPPS С. albicans is adequate and was used for the molecular docking.
Molecular docking of the compounds 1, 3 into the active site of FPPS was performed to mechanism interpretation of their high antifungal activity. Com- Fig. 3 . Quality of the built model FPPS C. albicans pound 7 was docked as a known FPPS L. major inhibitor, alendronate and risedronate -as N-BPs with known FPPS inhibition activity and antiparasitic properties (Fig. 6-10) . Fig. 6 data showed that one of the phosphonate groups forms the four electrostatic bonds (3.10-5.45 Å) with a catalytic magnesium ion and amino acid residues Asp99, Arg108, Asp239 the one metalacceptor bond with magnesium ion and the three hydrogen bonds (2.26-2.45 Å) with two water mole cules.
The other phosphonate group forms the seven electrostatic bonds (3.12-5.57 Å) with a catalytic magnesium ion and amino acid residues Asp99, Asp170, Lys196, Asp257, Lys262, the one metalacceptor bond (2.67 Å) with magnesium ion and the three hydrogen bonds (2.02-3.08 Å) with two water molecules and the amino acid residue Lys196. Also, the amino group of the ligand forms an electrostatic bond (3.24 Å) with the amino acid Asp99. Fig. 7 showed that the one phosphonate group forms the six electrostatic bonds (3.20-5.58 Å) with a catalytic magnesium ion and amino acid residues Asp99, Arg108, Asp239, Lys253, and the four hydrogen bonds (2.42-3.03 Å) with two water molecules and the amino acid Arg108.
The other phosphonate group forms the nine electrostatic bonds (2.98-5.15 Å) with catalytic magnesium ions and amino acid residues Asp99, Lys196, Lys262, the one metal-acceptor bond (2.81 Å) with a magnesium ion and the four hydrogen bonds (2.04-3.03 Å) with the three water molecules and the amino acid residue Lys196.
Fig. 4. The 3D profile of subunit A and B of FPPS C. albicans verified using ERRAT server
Also, the cyclohexyl group of the ligand forms the two hydrophobic bonds -Pi-alkyl (5.15 Å) and Alkyl (4.84 Å) with the amino acids Lys196 and Phe95.
Molecular docking results (Fig. 8) showed that the one phosphonate group forms the seven electrostatic bonds (3.03-5.33 Å) with catalytic magnesium ions and Asp99, Arg108, Lys196 amino acid residues, and the one metal-acceptor bond (3.15 Å) with a magnesium ion and the four hydrogen bonds (2.13-2.77 Å) with the four water molecules.
The other phosphonate group forms the six electrostatic bonds (4.26-5.49 Å) with a catalytic magnesium ion and the amino acid residues Arg108, Asp239, Arg254, and the one hydrogen bond (2.87 Å) with Arg108.
The pyridine ligand cycle forms a hydrophobic Pi-alkyl bond (4.87 Å) and an electrostatic Pi-cation bond (4.98 Å) with the amino acid Lys196.
Docking results (Fig. 9) showed that the one phosphonate group forms the six electrostatic bonds (3.09-5.49 Å) with catalytic magnesium ions and amino acid residues Arg108, Lys253, the one metalacceptor bond (3.03 Å) with magnesium ion and the two hydrogen bonds (2.20-2.52 Å) with the two water molecules.
The other phosphonate group forms the four electrostatic bonds (2.98-5.56 Å) with a catalytic magnesium ion and the amino acid residues Asp99, Lys196, Lys262, and the three hydrogen bonds (1.90-3.23 Å) with the two water molecules and Lys196.
Also, the hydroxyl ligand group forms a hydrogen bond (3.07 Å) with the amino acid residue Asp99.
And the ligand pyridine cycle forms a hydrogen bond (3.37 Å) with Asp99 and a hydrophobic Pi-alkyl bond (5.15 Å) and an electrostatic Pi-cation bond (4.66 Å) with Asp99.
Docking of alendronate (Fig. 10 ) demonstrated that the one phosphonate group forms the five electrostatic bonds (3.03-5.58 Å) with a catalytic magnesium ion and Asp99, Asp170, Lys262, and the five hydrogen bonds (1.90-3.34 Å) with the two water molecules and Lys196, Lys262.
The second phosphonate group forms the five electrostatic bonds (3.84-5.49 Å) with a catalytic magnesium ion and amino acid residues Asp99, Arg108, Asp239, Lys253, the one metal-acceptor The hydroxyl ligand group forms the two hydrogen bonds (2.65, 3.03 Å) with the water molecule and Asp99.
The amino group of the ligand forms the two hydrogen bonds (2.89, 2.98 Å) with Thr197 and Gln236.
A homology FPPS C.albicans model with high-quality scores has been developed and presented to confirmation of the molecular mechanism action of new nitrogen-containing bisphosphonates as anti-Candida agents. Molecular docking analysis of the studied compounds was performed based on the analysis of such known FPPS inhibitors as ammonium 2-(Pyridin-2-ylamino)ethylidene-1,1-bisphosphonate, risedronate and alendronate. The molecular docking results demonstrated a number of common features of the ligand's interaction into the active center FPPS C albicans. Thus, the phosphonate groups of all ligands are key elements in the formation of stable ligand-protein complexes due to a significant number of electrostatic, hydrogen and metal-acceptor bonds. The formed high stability of ligand-protein complexes demonstrated the binding energy in range (ΔG) from -6.6 to -7.1 kcal/mol. The amino acid residues Asp99, Arg108, Lys196, Lys253, Lys262, catalytic magnesium ions and water molecules were a key in the ligand-protein complexes creation. Thus, our studies have shown that the new studied compounds with high anti-Candida activity are FPPS inhibitors. У нашій попередній роботі було представ-лено низку нових нітрогенвмісних бісфосфона-тів (N-БФ) з високою передбаченою та експе-риментальною протигрибковою активністю як потенційні інгібітори фарнезилпірофосфатсин-тази (ФПФС) Candida albicans. Щоб підтвердити цю гіпотезу було розроблено гомологічну мо-дель ФПФС C. albicans із високими показниками якості і використано в цій роботі для вивчення молекулярного механізму дії активних N-БФ як антикандидозних агентів. Амоній-2-(піридин-2-іламіно) етиліден-1,1-бісфосфонатів, різедронат і алендронат використовували в молекулярно-му докінгу як відомі інгібітори ФПФС. Моле-кулярний докінг нових N-БФ продемонстрував низку загальних закономірностей взає модії всіх лігандів в активному центрі ФПФС C. albicans. Встановлено, що фосфонатні групи всіх лігандів є ключовими елементами в утворенні стабіль-них ліганд-протеїнових комплексів з енергією зв'язку в діапазоні (ΔG) від -6,6 до -7,1 ккал/моль завдяки значній кількості електростатичних, водневих і металакцепторних зв'язків. Було під-тверджено, що нові вивчені N-БФ 1 і 3 з високою протикандидозною активністю є інгібіторами ФПФС.
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